RxDoctor Payments Data

Patrick Kelly, MD

Vascular Surgery · Sioux Falls, SDNPI 1134189160

Payments from drug & device makers

What this record shows

36 manufacturers reported payments, led by Medtronic at 32.1% of the total. 2025 is the largest year on record at $4,744, 3.5 times the $1,344 reported in 2019.

$13,813in general payments, 2019–2025

Across 174 payments — averaging $79.38 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medtronic$4K
  • Bolton Medical Inc$4K
  • W. L. Gore & Associates, Inc.$3K
  • Lemaitre Vascular, Inc.$613
  • Bard Peripheral Vascular, Inc.$349
  • Boston Scientific$264
  • plus $2K from 30 others
$464,648in research payments, 2019–2025

Across 90 payments — averaging $5162.75 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Medtronic$459K
  • W. L. Gore & Associates, Inc.$4K
  • Cardiovascular Systems Inc.$2K

What the payments were for

  • Travel & lodging$6,01044%
  • Food & beverage$7,80356%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

Too few vascular surgery providers in South Dakotato place this figure against a meaningful peer group, so we don't.

Medicare billing

Part B allowed, 2024
$1,967,103
Medicare patients
518
Services billed
18,953

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Vancomycin Hcl17$2,869
ClopidogrelClopidogrel Bisulfate26$143
Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim13$58

Paid to pharmacies, not to this prescriber.

Other vascular surgery in Sioux Falls

See the full list for South Dakota

Where these figures come from

Is this you, or does something look wrong? →